Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-021062

Chief Financial Officer gave up 31,734 shares (to pay taxes)

  • Chief Financial Officer acquired 58,590 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-03 Exercise or conversion : show line 1 in the form +58,590 87,938 D
2025-03-03 Shares withheld for taxes : show line 2 in the form −31,734 $4.04 $128,205 56,204 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −58,590 70,317 D
Loading xslF345X05/tm258333-5_4seq1.xml…